Dr. Robert F. Caspari served as Chief Operating Officer and Chief Medical Officer at Riot Pharmaceuticals, joining the company on February 10, 2009. His employment agreement, entered into on February 2, 2009, provided for four months of severance upon termination without cause or in the event of a change of control, with the same provision applying for death or disability. Dr. Caspari resigned from his positions effective August 20, 2010 and subsequently provided consulting services to assist with transition matters and company projects.
Biography extracted from Riot DEF 14A filed 2010-10-22 View cached copy (2026-09-27)Live source ↗
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Riot | COO & Chief Medical Officer | 2009-02 → present (17y 9mo) | 3 |
Show 3 underlying filings | |||
Compensation
| Year | Role as filed | Salary | Option awards | Incentive | Other | Total | Source |
|---|---|---|---|---|---|---|---|
| 2009 | — | $222.6K | $445.2K | $50.0K | $10.5K | $728.3K | View cached copy (2026-09-27)Live source ↗ |
As reported in the company's DEF 14A Summary Compensation Table (SEC Reg S-K Item 402(c)). Stock and option awards are grant-date fair values — what the award was worth on the day it was granted, not cash received and not what it is worth now. Every row here reconciles: its columns add up to the total the filing printed.
Insider transactions
Totals for this person
| Bucket | Invested (shares) | Invested (USD) | Divested (shares) | Divested (USD) | Net direction | Txns | Invested @ last price | Divested @ last price |
|---|---|---|---|---|---|---|---|---|
| All time | 53,200 | $5.0K | - | $0 | ↑ Invested $5.0K | 3 | $681.5K | $0 |
| 2010 | 50,000 | $0 | - | $0 | Flat | 1 | $640.5K | $0 |
| 2009 | 3,200 | $5.0K | - | $0 | ↑ Invested $5.0K | 2 | $41.0K | $0 |
| 2009-Q2 | 3,200 | $5.0K | - | $0 | ↑ Invested $5.0K | 2 | $41.0K | $0 |
| 2010-Q1 | 50,000 | $0 | - | $0 | Flat | 1 | $640.5K | $0 |
Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-10-30); they are a valuation, not a cash flow, and they move every day the market does.
All transactions
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2010-01-19 | Riot | Grant / award / vesting · Option - Right to Buy | 50,000 | - | $640.5K |
| 2009-05-18 | Riot | Open-market purchase | 2,100 | $3,297 | $26.9K |
| 2009-05-18 | Riot | Open-market purchase | 1,100 | $1,727 | $14.1K |